source
- Series B funded biotechs expand hiring, Tenpoint Therapeutics raises $85M for eye-health pipelineCompanies that secured series B rounds this year are scaling up their staff, making them attractive targets for biopharma talent. Tenpoint Therapeutics, based in Warren, New Jersey, announced an $…
- Travere appoints former Amicus CEO Bradley Campbell as new chief executiveTravere Therapeutics CEO Eric Dube is stepping down after overseeing the launch of the rare kidney disease drug Filspari. Bradley Campbell will assume the role on Dec 1, bringing experience from l…